Tom Böhling

9.7k total citations · 1 hit paper
187 papers, 6.7k citations indexed

About

Tom Böhling is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Tom Böhling has authored 187 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Oncology, 79 papers in Pulmonary and Respiratory Medicine and 40 papers in Rheumatology. Recurrent topics in Tom Böhling's work include Sarcoma Diagnosis and Treatment (68 papers), Polyomavirus and related diseases (48 papers) and Full-Duplex Wireless Communications (34 papers). Tom Böhling is often cited by papers focused on Sarcoma Diagnosis and Treatment (68 papers), Polyomavirus and related diseases (48 papers) and Full-Duplex Wireless Communications (34 papers). Tom Böhling collaborates with scholars based in Finland, Sweden and Italy. Tom Böhling's co-authors include Virve Koljonen, Erkki Tukiainen, Harri Sihto, Sakari Knuutila, Heikki Joensuu, Heli Kukko, Risto Sankila, Maija Tarkkanen, Piero Picci and Matti Haltia and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Tom Böhling

183 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

2011 470 citations Netta Mäkinen, Miika Mehine et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Böhling Finland	42	2.5k	2.1k	1.7k	1.1k	1.0k	187	6.7k
Axel zur Hausen Germany	40	3.5k 1.4×	676 0.3×	2.7k 1.6×	1.8k 1.7×	851 0.8×	140	6.6k
Victor E. Gould United States	53	3.2k 1.2×	1.5k 0.7×	1.8k 1.0×	658 0.6×	234 0.2×	189	7.9k
Cornelia Mauch Germany	49	3.0k 1.2×	684 0.3×	2.7k 1.6×	1.4k 1.4×	268 0.3×	208	7.9k
Gary L. Gallia United States	47	1.1k 0.4×	1.0k 0.5×	1.8k 1.0×	539 0.5×	234 0.2×	235	6.9k
Paul W. Harms United States	35	2.2k 0.9×	404 0.2×	935 0.6×	310 0.3×	821 0.8×	126	4.4k
Juan P. Rodrigo Spain	53	3.7k 1.5×	2.0k 0.9×	2.4k 1.4×	1.4k 1.3×	203 0.2×	411	10.3k
Mahesh Mansukhani United States	42	2.0k 0.8×	1.5k 0.7×	3.6k 2.1×	1.5k 1.4×	214 0.2×	163	6.8k
Steven D. Billings United States	36	1.9k 0.8×	2.1k 1.0×	749 0.4×	253 0.2×	173 0.2×	239	4.8k
Genevieve M. Boland United States	30	2.3k 0.9×	584 0.3×	2.1k 1.3×	744 0.7×	169 0.2×	121	5.6k
Mehrdad Nadji United States	41	1.7k 0.7×	956 0.5×	1.6k 0.9×	701 0.7×	98 0.1×	169	5.6k

Countries citing papers authored by Tom Böhling

Since Specialization

Citations

This map shows the geographic impact of Tom Böhling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Böhling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Böhling more than expected).

Fields of papers citing papers by Tom Böhling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Böhling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Böhling. The network helps show where Tom Böhling may publish in the future.

Co-authorship network of co-authors of Tom Böhling

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Böhling. A scholar is included among the top collaborators of Tom Böhling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Böhling. Tom Böhling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Almusa, Henrikki, et al.. (2025). Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromas. Orphanet Journal of Rare Diseases. 20(1). 70–70.

Böhling, Tom, et al.. (2023). Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma. Annals of Surgical Oncology. 30(7). 4489–4497. 5 indexed citations

Kilpinen, Sami, et al.. (2023). Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International Journal of Cancer. 152(10). 2099–2108. 8 indexed citations

Böhling, Tom, et al.. (2021). ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival. PLoS ONE. 16(5). e0252099–e0252099. 5 indexed citations

Salminen, S, Tom Wiklund, Mika Sampo, et al.. (2019). Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population. Annals of Surgical Oncology. 27(4). 1002–1010. 22 indexed citations

Kero, Mia, et al.. (2018). ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma. Histopathology. 74(6). 829–835. 4 indexed citations

Rönty, Mikko, Tom Böhling, Christina Karlsson, et al.. (2018). High cyclin A expression, but not Ki67, is associated with early recurrence in desmoid tumors. Journal of Surgical Oncology. 118(1). 192–198. 5 indexed citations

Sahi, Helka, et al.. (2014). miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(3). 289–295. 24 indexed citations

Sihto, Harri, Tom Böhling, Heli Kavola, et al.. (2012). Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study. Clinical Cancer Research. 18(10). 2872–2881. 113 indexed citations

10.

Mäkinen, Netta, Miika Mehine, Jaana Tolvanen, et al.. (2011). MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas. Science. 334(6053). 252–255. 470 indexed citations breakdown →

11.

Sihto, Harri, Heli Kukko, Virve Koljonen, et al.. (2011). Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma. Clinical Cancer Research. 17(14). 4806–4813. 142 indexed citations

12.

Sampo, Mika, Mika P. Koivikko, Mervi Taskinen, et al.. (2011). Incidence, epidemiology and treatment results of osteosarcoma in Finland – a nationwide population-based study. Acta Oncologica. 50(8). 1206–1214. 63 indexed citations

13.

Bjerkehagen, Bodil, Johan Wejde, Magnus Hansson, Henryk A. Domanski, & Tom Böhling. (2009). SSG pathology review experiences and histological grading of malignancy in sarcomas. Acta Orthopaedica. 80(334). 31–36. 6 indexed citations

14.

Sihto, Harri, Heli Kukko, Virve Koljonen, et al.. (2009). Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma. JNCI Journal of the National Cancer Institute. 101(13). 938–945. 227 indexed citations

15.

Niemelä, Mika, Markku Sainio, Eero Pukkala, et al.. (2000). Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.. PubMed. 41(7). 1909–15. 35 indexed citations

16.

Kivioja, Aarne, et al.. (2000). Chondrosarcoma in a family with multiple hereditary exostoses. Journal of Bone and Joint Surgery. 82(2). 261–266. 3 indexed citations

17.

Larramendy, Marcelo L., Nils Mandahl, Fredrik Mertens, et al.. (1999). Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas. Human Pathology. 30(10). 1247–1253. 24 indexed citations

18.

Gamberi, Gabriella, Maria Serena Benassi, Tom Böhling, et al.. (1998). <i>C-myc</i> and <i>c-fos</i> in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression. Oncology. 55(6). 556–563. 143 indexed citations

19.

Böhling, Tom, Ossi Turunen, Juha E. Jääskeläinen, et al.. (1996). Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors.. PubMed. 148(2). 367–73. 71 indexed citations

20.

Hatva, E, Tom Böhling, Juha E. Jääskeläinen, et al.. (1996). Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. The American Journal of Surgical Pathology. 148. 763–775. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact